LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

Photo by freestocks from unsplash

David M. Alvarado, PhD,∗,# Juhee Son, BS,† Larissa B. Thackray, PhD,‡ Maria Florencia, Gomez Castro PhD,† Sarada Prasad, BS,∗ Xueyang Cui, MD,∗,¶ Naomi M Sonnek, MS,∗ Michael S. Diamond, MD,… Click to show full abstract

David M. Alvarado, PhD,∗,# Juhee Son, BS,† Larissa B. Thackray, PhD,‡ Maria Florencia, Gomez Castro PhD,† Sarada Prasad, BS,∗ Xueyang Cui, MD,∗,¶ Naomi M Sonnek, MS,∗ Michael S. Diamond, MD, PhD,†,‡,§ Siyuan Ding, PhD,† and Matthew A. Ciorba, MD∗,#, From the ∗Inflammatory Bowel Diseases Center, Division of Gastroenterology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA †Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA ‡Divison of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA §Divison of Pathology and Immunology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA ¶Department of Anorectal Surgery, The First Affiliated Hospital of China Medical University, Liaoning, China #These two authors contributed equally to this article. Address correspondence to: Matthew A. Ciorba, MD 660 S. Euclid St., Campus Box 8124, St. Louis, MO, 63110, USA ([email protected]).

Keywords: phd; university louis; medicine; washington university; department

Journal Title: Inflammatory Bowel Diseases
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.